Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705860 · ClinicalTrials.gov registry record
Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation
A clinical trial of Follow up to Acute Wound Scar Study, sponsored by Healthpoint.
- Completed
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT01705860 is a study of Follow up to Acute Wound Scar Study that has completed, run by Healthpoint. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01705860, a study of Follow up to Acute Wound Scar Study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The present study will evaluate the long term effects on scar formation for dermatome-induced skin wounds treated with Collagenase Santyl® Ointment or vehicle (white petrolatum ointment) alone. The previous study, 017-101-09-001, utilized a small, experimental, cutaneous wound to evaluate both time to complete wound closure and quality of the resulting scar when Collagenase Santyl® Ointment was used to treat the wound.
Conditions Studied
Interventions
- BIOLOGICAL Santyl
Study Locations (1)
Texas
- - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01705860
The ClinicalTrials.gov registry entry for NCT01705860 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Follow up to Acute Wound Scar Study appearing as the primary indexed condition, and to 1 intervention - of which Santyl is the first listed.
NCT01705860 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01705860 about?
NCT01705860 is a clinical study titled "Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation". The present study will evaluate the long term effects on scar formation for dermatome-induced skin wounds treated with Collagenase Santyl® Ointment or vehicle (white petrolatum ointment) alone. The previous study, 017-101-09-001, utilized a small, experimental, cutaneous wound to evaluate both time ...
What is the current status of trial NCT01705860?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2012-09. Estimated completion is 2013-04.
What conditions does trial NCT01705860 study?
This clinical trial studies the following conditions: Follow up to Acute Wound Scar Study.
What interventions are being tested in trial NCT01705860?
The interventions under investigation include: Santyl (BIOLOGICAL).
Who is sponsoring clinical trial NCT01705860?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01705860 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.